Page last updated: 2024-10-24

celiprolol and Tachycardia

celiprolol has been researched along with Tachycardia in 2 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rameis, H1
Magometschnigg, D1
Uprichard, AC1
Chi, LG1
Kitzen, JM1
Lynch, JJ1
Frye, JW1
Lucchesi, BR1

Trials

1 trial available for celiprolol and Tachycardia

ArticleYear
[Therapeutic problems in hyperkinetic heart syndrome].
    Acta medica Austriaca, 1984, Volume: 11, Issue:1

    Topics: Adrenergic beta-Antagonists; Celiprolol; Clinical Trials as Topic; Female; Heart Rate; Humans; Male;

1984

Other Studies

1 other study available for celiprolol and Tachycardia

ArticleYear
Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 251, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Celiprolol; Death, Sudden; Dogs; Elect

1989